Medicare Enrolled

Dr. Joshua Rodriguez, M.D., PHARM. D.

Pharmacist · El Paso, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1901 GRANDVIEW AVE, El Paso, TX 79902
9155446750
In practice since 2011 (14 years)
NPI: 1972871374 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodriguez

Dr. Joshua Rodriguez is a pharmacist in El Paso, TX, with 14 years in practice. Based on federal Medicare data, Dr. Rodriguez performed 33,425 Medicare services across 1,611 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rodriguez received a total of $537 from 7 pharmaceutical and/or device companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pharmacist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodriguez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 7% volume in TX$ $537 industry payments

Medicare Practice Summary

Medicare Utilization ↗
33,425
Medicare services
Top 7% in TX for pharmacist
1,611
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,388 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)8,670$0$5
Pembrolizumab injection (Keytruda)7,400$43$137
Anti-nausea injection (fosaprepitant)6,000$0$5
Darbepoetin injection (Aranesp) for anemia4,120$2$20
Denosumab injection (Prolia/Xgeva)1,440$18$66
Dexamethasone injection (steroid)1,106$0$1
Injection, granisetron hydrochloride, 100 mcg570$0$24
Anti-nausea injection (Aloxi/palonosetron)530$1$114
Blood draw (venipuncture)404$8$20
Complete blood count (CBC) with differential346$8$36
Comprehensive metabolic blood panel334$10$64
Injection of additional new drug or substance into vein326$11$108
Office visit, established patient (20-29 min)307$63$250
Office visit, established patient (30-39 min)217$88$368
Administration of chemotherapy into vein, 1 hour or less200$96$707
Injection, carboplatin, 50 mg138$2$300
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle102$54$211
Hospital follow-up visit, moderate complexity102$61$247
Injection, zoledronic acid, 1 mg89$7$431
Initial hospital admission, moderate complexity87$98$470
Injection, diphenhydramine hcl, up to 50 mg80$1$7
Drug injection, under skin or into muscle74$10$96
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less67$21$157
Administration of chemotherapy into vein, each additional hour63$21$161
Irrigation of implanted venous access drug delivery device58$18$114
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle56$24$145
Administration of additional new drug or substance into vein, 1 hour or less56$48$344
Unclassified drugs40$1$8
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less37$47$313
New patient office visit (45-59 min)37$121$565
Lactate dehydrogenase (enzyme) level36$6$31
Carcinoembryonic antigen (cea) protein level33$19$99
Microscopic examination for white blood cells with manual cell count30$4$22
Complete blood count (CBC), automated30$6$34
Administration of additional new drug or substance into vein using push technique30$42$289
Ferritin level test (iron stores)29$13$60
Iron level test27$6$27
Iron binding capacity test27$9$35
Infusion into a vein for hydration, each additional hour26$8$75
Infusion, normal saline solution , 1000 cc23$2$19
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session20$272$2,762
Vitamin B-12 level test17$15$76
Folic acid level test16$14$73
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries14$90$657
New patient office visit (30-44 min)11$62$372
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.4% high complexity
66.7% medium
6.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$537
Total received (2019-2024)
Avg $107/year across 5 years
Bottom 47% in TX for pharmacist
7
Companies
14
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$404 (75.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$134 (24.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$35
2023
$176
2021
$115
2020
$74
2019
$138

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$189
Gilead Sciences, Inc.
$176
Takeda Pharmaceuticals U.S.A., Inc.
$76
E.R. Squibb & Sons, L.L.C.
$33
Genentech USA, Inc.
$24
Lexicon Pharmaceuticals, Inc.
$23
Seagen Inc.
$16
Top 3 companies account for 82.2% of total payments
Associated products mentioned in payments ›
ALUNBRIG · Kyprolis · Neulasta · Nplate · OPDIVO · TECENTRIQ · TUKYSA · Trodelvy · Xermelo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a pharmacist in El Paso?
Compare pharmacists in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse pharmacists nearby

Geographic Context

Pharmacists within 10 mi
518
Per 100K population
59.8
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rodriguez is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rodriguez experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rodriguez performed 8,670 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez received a total of $537 from 7 companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez's costs compare to other pharmacists in El Paso?
Dr. Rodriguez's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →